Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.46 Analyst target: $6.67 Upside: 356.85%
Innate Pharma SA, a biotechnology company, discovers, develops and markets therapeutic antibodies for the treatment of oncological indications in France and internationally. The company is headquartered in Marseille, France.
See the full interactive analysis & chart →Informational only — not investment advice.